MESOBLAST FPO (ASX: MSB) Share Price and News

Why Blackmores, Class, Mesoblast, & St Barbara shares raced higher today

James Mickleboro | September 12, 2019 1:45pm

The Blackmores Limited (ASX:BKL) share price and the Mesoblast limited (ASX:MSB) share price are two of four racing higher on Thursday... More »

Why Mesoblast, New Hope, Pilbara Minerals, & Syrah shares charged higher today

James Mickleboro | September 11, 2019 1:49pm

The Mesoblast limited (ASX:MSB) share price and the Syrah Resources Ltd (ASX:SYR) share price are two of four charging notably higher today... More »

Paradigm share price tanks despite positive clinical trial update

Tom Richardson | September 10, 2019 2:50pm

Paradigm Biopharmaceuticals Ltd (ASX: PAR) is a speccy biotech that could sink or soar. More »

Why the Mesoblast share price is going nuts today

Tom Richardson | September 10, 2019 2:34pm

Mesoblast limited (ASX: MSB) has signed an important partnership with Grünenthal. More »

Why iSignthis, Leigh Creek, Mesoblast, & Santos shares charged higher

James Mickleboro | September 10, 2019 1:10pm

The iSignthis Ltd (ASX:ISX) share price and the Mesoblast limited (ASX:MSB) share price are two of four charging higher on Tuesday... More »

Mesoblast share price rockets 17% higher on Grünenthal partnership news

James Mickleboro | September 10, 2019 10:46am

The Mesoblast Limited (ASX:MSB) share price has rocketed higher on Tuesday following the release of a positive update relating to its MPC-06-ID product... More »

Opthea share price lifts on clinical trial update: Is it a spec buy?

Tom Richardson | September 6, 2019 11:33am

Opthea Ltd (ASX: OPT) is developing clinical treatments for eye diseases. More »

Mesoblast share price edges higher on quarterly update

Ken Hall | August 1, 2019 10:09am

The Mesoblast Ltd (ASX: MSB) share price closed 0.6% higher on the ASX yesterday after the company reported its June 2019 quarterly update. More »

Biotech speccy Paradigm is being tipped for the big time

Tom Richardson | July 31, 2019 3:16pm

Paradigm (ASX: PAR) has $78 million cash on hand and a goal to commercialise osteoarthritis drugs. More »

High profile fundie warns these 10 ASX shares have “bubble” valuations

Tom Richardson | July 16, 2019 12:01pm

Bubs Australia Ltd (ASX: BUB), Audinate Group Ltd (ASX: AD8) and other popular shares are in the firing line. More »

Telix Pharmaceuticals just boasted it’s one step closer to getting a cancer treatment approved

Tom Richardson | July 15, 2019 2:16pm

Telix Pharmaceuticals Ltd (ASX:TLX) could hand investors huge gains or losses. More »

Is the Starpharma share price a buy?

Mitchell Perry | July 5, 2019 3:39pm

The Starpharma Holdings Limited (ASX: SPL) share price has gained 50% since the end of December 2018. Is it a buy? More »

Why Adairs, Ausdrill, Domino’s, & Mesoblast shares charged higher today

James Mickleboro | June 24, 2019 1:26pm

The Ausdrill Limited (ASX:ASL) share price and the Domino's Pizza Enterprises Ltd (ASX:DMP) share price are two of four starting the week on a... More »

Why the Mesoblast share price zoomed 7% higher today

James Mickleboro | June 24, 2019 11:06am

The Mesoblast Limited (ASX:MSB) share price has been on fire on Monday. Here's why... More »